Let's see how we do on the next pandemic if we screw the IP out of all of the producers who stepped up to produce a vaccine.

If the scenario is that they'd still have their mRNA IP if they had decided not to make a vaccine, that is not the incentive structure we want to setup.

It's also not where the constraint lies.

Of course it would have been great for people who are already dealing with malaria and HIV to inject with a vaccine put together in a factory somewhere in Kinshasa where the measuring instruments for quantities are just two : left and right eyeball.